Systemic Lupus Erythematosus Responder Index Assessment of Responders in EMBLEM, a Phase IIb Study in Patients with Moderate to Severe Systemic Lupus Erythematosus

被引：0
|
作者：
Petri, Michelle [1 ]
Pike, Marilyn C. [2 ]
Kelley, Lexy [3 ]
Kilgallen, Brian [4 ]
Gordon, Caroline [5 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[2] Med Pharm Consulting Inc, Cambridge, MA USA
[3] UCB, Smyrna, GA USA
[4] UCB, Brussels, Belgium
[5] Univ Birmingham Sch Med, Birmingham B15 2TT, W Midlands, England
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1378
引用
收藏
页码：S539 / S539
页数：1
相关论文
共 50 条
  • [11] SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) RESPONDER INDEX [SRI(4)] RESPONSE IS ASSOCIATED WITH GLOBAL BENEFIT IN PATIENTS WITH MODERATE TO SEVERE SLE
    Furie, R.
    Wang, L.
    Drappa, J.
    Illei, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S87 - S87
  • [12] The Systemic Lupus Erythematosus Responder Index (SRI); A new SLE disease activity assessment
    Luijten, K. M. A. C.
    Tekstra, J.
    Bijlsma, J. W. J.
    Bijl, M.
    AUTOIMMUNITY REVIEWS, 2012, 11 (05) : 326 - 329
  • [13] Novel Evidence-Based Systemic Lupus Erythematosus Responder Index
    Furie, Richard A.
    Petri, Michelle A.
    Wallace, Daniel J.
    Ginzler, Ellen M.
    Merrill, Joan T.
    Stohl, William
    Chatham, W. Winn
    Strand, Vibeke
    Weinstein, Arthur
    Chevrier, Marc R.
    Zhong, Z. John
    Freimuth, William W.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (09): : 1143 - 1151
  • [14] The study of Cutaneous Lupus Erythematosus Disease Area and Severity Index in Indian patients with systemic lupus erythematosus
    Salphale, P.
    Danda, D.
    Chandrashekar, L.
    Peter, D.
    Jayaseeli, N.
    George, R.
    LUPUS, 2011, 20 (14) : 1510 - 1517
  • [15] High Systemic Lupus Erythematosus Disease Activity Index is the Predictor for Cardiorenal Syndrome in Systemic Lupus Erythematosus Patients
    Lee, Jin Bae
    Bae, Kyung Yun
    Jern, Sung Hoon
    Hong, Sung Pyo
    Lee, Young Soo
    Ryu, Jae Kern
    Choi, Ji Yong
    Kim, Kee Sik
    Chang, Sung Gug
    CIRCULATION, 2013, 128 (22)
  • [16] Severe hypercalcemia and systemic lupus erythematosus
    Gazzaruso, C
    Montecucco, CM
    Geroldi, D
    Garzaniti, A
    Finardi, G
    JOINT BONE SPINE, 2000, 67 (05) : 485 - 488
  • [17] Rituximab for severe systemic lupus erythematosus
    Carrillo-Vàzquez, M
    Reyes-Salinas, A
    Saavedra-Salinas, MA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 248 - 248
  • [18] A Phase 3 Randomized Controlled Trial of Anifrolumab in Patients with Moderate to Severe Systemic Lupus Erythematosus
    Furie, Richard
    Morand, Eric
    Bruce, Ian
    Manzi, Susan
    Kalunian, Kenneth
    Vital, Edward
    Lawrence-Ford, Theresa
    Gupta, Ramesh
    Hiepe, Falk
    Santiago, Mittermayer
    Brohawn, Philip
    Berglind, Anna
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [19] Lupus mastitis associated with severe systemic erythematosus lupus
    Guerre, A. -R.
    Pelletier, F.
    Aubin, F.
    Humbert, P.
    REVUE DE MEDECINE INTERNE, 2009, 30 (06): : 540 - 542
  • [20] TREATMENT OF PATIENTS WITH MODERATE-TO-SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE SEVERITY
    Strand, V.
    Johnson, J.
    Vandeloo, C.
    Galateanu, C.
    Lobosco, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1171 - 1171
12345